India at no. 5 in the world for science research, says new global report

Research assistants work at the reversible inhibition of sperm under guidance (RISUG) male contraceptive treatment research and development laboratory at the Indian Institute of Technology (IIT) Kharagpur in Kharagpur, West Bengal, India, on Feb. 16, 2017. A new birth control method for men has the potential to win as much as half the $10 billion market for female contraceptives worldwide and cut into the $3.2 billion of annual condom sales, businesses dominated by pharmaceutical giants Bayer AG, Pfizer Inc. and Merck & Co., according to estimates from the last major drug company to explore the area. Photographer: Sumit Dayal/Bloomberg